• Publications
  • Influence
Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
It is indicated that ceftriaxone at a dosage of 2 or 1 g daily is at least as effective as cefotaxime given daily at a dose of 4 g in the treatment of severe lower respiratory tract infections.
Long‐term absence of sensitization to mepivacaine as assessed by a diagnostic protocol including patch testing
Allergy consultation is a frequent reason for allergy consultation and exploratory assessment of non‐reactivity to local anaesthetics is a Frequent Reason for Allergy consultation.
Bacteriological and Clinical Evaluation of Sisomicin, a New Aminoglycoside Antibiotic
Sisomicin exerts a high antibacterial (bactericidal) activity against Pseudomonas, most Coliform Bacilli and Staphylococcus aureus strains.
Clinical evaluation of tobramycin in urinary tract infections.
Twenty-one patients with urinary tract infections due to Pseudomonas and coli-form bacilli were treated with 80-120 mg of tobramycin per day in two daily doses and urine cultures demonstrated rapid sterilization in the cases in which patients responsed well.
Epidemiology of allergic occupational diseases induced by Tetranychus urticae in greenhouse and open‐field farmers living in a temperate climate area
The role of Tetranychus urticae as an occupational allergen has thus far been investigated only in selected farmer samples and the results suggest that TU should be investigated further in order to determine its role in agriculture.
Gastroesophageal reflux disease and asthma: an intriguing dilemma
There is persistent debate about the pathophysiologic mechanisms triggering asthma by GOR, but evidence is accumulating that these mechanisms are likely to be related to each other.
Clinical evaluation of tobramycin in respiratory and systemic infections in immunodepressed and normal patients.
Combined treatment with tobramycin and beta-lactam antibiotics resulted in clinical and bacteriological improvement in 50% of systemic immunodepressed patients with sepsis and/or pneumonia.
Design and rationale of the COVID-19 Critical Care Consortium international, multicentre, observational study
This is an international, multicentre, observational study of patients with confirmed or suspected SARS-CoV-2 infection admitted to ICUs and follows them to the time of death, hospital discharge or 28 days post-ICU admission, whichever occurs last.